Boc-Velpatasvir R Isomer - Request Quote
Boc-Velpatasvir R Isomer
| SZ CAT No: | SZ-V013086 |
| CAS No | NA |
| Mol.F. | C44H53N7O7 |
| Mol.Wt. |
792.0 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Boc-Velpatasvir R Isomer is chemically Tert-butyl (2S,4R)-2-(5-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidine-1-carboxylate. Boc-Velpatasvir R Isomer is supplied with detailed characterization data compliant with regulatory guideline. Boc-Velpatasvir R Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Velpatasvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Boc-Velpatasvir R Isomer
Purchase Boc-Velpatasvir R Isomer
Boc-Velpatasvir R Isomer suppliers
Boc-Velpatasvir R Isomer manufacturers
Boc-Velpatasvir R Isomer price
Order Boc-Velpatasvir R Isomer
Enquire Boc-Velpatasvir R Isomer
Boc-Velpatasvir R Isomer cost
Boc-Velpatasvir R Isomer Supplier
Boc-Velpatasvir R Isomer Distributor
Boc-Velpatasvir R Isomer for Method Validation
Velpatasvir Reference Standard
Boc-Velpatasvir R Isomer for ANDA Filing
Boc-Velpatasvir R Isomer for Forced Degradation Studies
Boc-Velpatasvir R Isomer Identification Standards
Boc-Velpatasvir R Isomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


